Antimitochondrial antibodies in primary biliary cirrhosis

Seminars in Liver Disease

Volumn 17, Issue 1, 1997, Pages 61-69

  Leung, Patrick S C ^a   Coppel, Ross L ^b   Ansari, Aftab ^c   Munoz, Santiago ^d   Gershwin, M Eric ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MONASH UNIVERSITY   (Australia)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d ALBERT EINSTEIN MEDICAL CENTER   (United States)

Author keywords

2 oxo acid dehydrogenase complex; bile duct epithelium; cross reactive molecule; epitope; Ig gene; PDC E2

Indexed keywords

MITOCHONDRION ANTIBODY; MONOCLONAL ANTIBODY;

ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ARTICLE; COMPLEX FORMATION; ENZYME SPECIFICITY; EPITOPE MAPPING; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MOLECULAR CLONING; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; PROTEIN ASSEMBLY;

EID: 0030914714     PISSN: 02728087     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1007183     Document Type: Article

References (72)

1. Mackay IR: Primary biliary cirrhosis showing high titer of autoantibody: report of a case. N Engl J Med 254-185, 1958.
2. Walker JG, Doniach D, Roitt IM, Sherlock S: Serological tests in the diagnosis of primary biliary cirrhosis. Lancet 1:827-30, 1965.
3. Frazer IH, Mackay IR, Jordan TW, et al: Reactivity of antimitochondrial autoantibodies in primary biliary cirrhosis: definition of two novel mitochondrial polypeptide autoantigens. J Immunol 135:1739-45, 1985.
4. Lindenborn-Fotinos J, Baum H, Berg PA: Mitochondrial antibodies in primary biliary cirrhosis: species and nonspecies specific determinants of M2 antigen. Hepatology 5:763-9, 1985.
5. Mendel-Hartvig I, Nelson BD, Loof L, Totterman TH: Primary biliary cirrhosis: further biochemical and immunological characterization of mitochondrial antigens. Clin Exp Immunol 62.371-9, 1985.
6. Mendel-Hartvig I, Frostell A, Totterman TH: Primary biliary cirrhosis: antigenic specificity of IgM-type mitochondrial antibodies analyzed by immunoblotting and ELISA. Intl Arch All App Immunol 83:265-70, 1987.
7. Gershwin ME, Mackay IR, Sturgess A, Coppel RL: Identification and specificity of a cDNA encoding the 70 kd mitochondrial antigen recognized in primary biliary cirrhosis. J Immunol 138:3525-31, 1987.
8. Van de Water J, Gershwin ME, Leung P, et al: The autoepitope of the 74-kD mitochondrial autoantigen of primary biliary cirrhosis corresponds to the functional site of dihydrolipoamide acetyltransferase. J Exp Med 167:1791-9, 1988.
9. Coppel RL, McNeilage LJ, Surh CD, et al: Primary structure of the human M2 mitochondrial autoantigen of primary biliary cirrhosis: dihydrolipoamide acetyltransferase. Proc Natl Acad Sci USA 85:7317-21, 1988.
10. Surh CD, Danner DJ, Ahmed A, et al: Reactivity of primary biliary cirrhosis sera with a human fetal liver cDNA clone of branched-chain alpha-keto acid dehydrogenase dihydrolipoamide acyltransferase, the 52 kD mitochondrial autoantigen. Hepatology 9:63-8, 1989.
11. Baum H, Berg PA: The complex nature of mitochondrial antibodies and their relation to primary biliary cirrhosis. Review. Sem Liv Dis 1:309-21, 1981.
12. Yeaman SJ, Fussey SP, Danner DJ, et al: Primary biliary cirrhosis: identification of two major M2 mitochondrial autoantigens. Lancet 1:1067-70, 1988.
13. Fregeau DR, Davis PA, Danner DJ, et al: Antimitochondrial antibodies of primary biliary cirrhosis recognize dihydrolipoamide acyltransferase and inhibit enzyme function of the branched chain alpha-ketoacid dehydrogenase complex. J Immunol 142: 3815-20, 1989.
14. Fussey SP, Guest JR, James OF, et al: Identification and analysis of the major M2 autoantigens in primary biliary cirrhosis. Proc Natl Acad Sci USA 85:8654-8, 1988.
15. Fregeau DR, Prindiville T, Coppel RL, et al: Inhibition of alpha-ketoglutarate dehydrogenase activity by a distinct population of autoantibodies recognizing dihydrolipoamide succinyltransferase in primary biliary cirrhosis. Hepatology 11:975-81, 1990.
16. Fussey SP, Bassendine MF, Fittes D, et al: The E1 alpha and beta subunits of the pyruvate dehydrogenase complex are M2'd' and M2'e' autoantigens in primary biliary cirrhosis. Clin Sci 77:365-8, 1989.
17. Surh CD, Roche TE, Danner DJ, et al: Antimitochondrial autoantibodies in primary biliary cirrhosis recognize cross-reactive epitope(s) on protein X and dihydrolipoamide acetyltransferase of pyruvate dehydrogenase complex. Hepatology 10: 127-33, 1989.
18. Mackay IR, Gershwin ME: Primary biliary cirrhosis: considerations on pathogenesis based on identification of the M2 autoantigens. Semin Immunopathol 12:101-19, 1990
19. Yeaman SJ: The mammalian 2-oxoacid dehydrogenases: a complex family. Trends Biochem Sci 11:293-7, 1986.
20. Van de Water J, Fregeau D, Davis P, et al. Autoantibodies of primary biliary cirrhosis recognize dihydrolipoamide acetyltransferase and inhibit enzyme function. J Immunol 141:2321-4, 1988.
21. Uibo R, Mackay IR, Rowley M, et al: Inhibition of enzyme function by human autoantibodies to an autoantigen pyruvate dehydrogenase E2: different epitope for spontaneous human and induced rabbit autoantibodies. Clin Exp Immunol 80.19-24, 1990.
22. Sundin U: Antibody binding and inhibition of pyruvate dehydrogenase (PDH) in sera from patients with primary biliary cirrhosis. Clin Exp Immunol 81:238-43, 1990.
23. Coppel RL, Gershwin ME: Primary biliary cirrhosis: The molecule and the mimic. Immunol Rev 144:17-49, 1995.
24. Leung PSC, Chuang DT, Wynn RM, et al: Autoantibodies to BCOADC-E2 in patients with primary biliary cirrhosis recognize a conformational epitope. Hepatology 22.505-13, 1995.
25. Van de Water J, Cooper A, Surh CD, et al: Detection of autoantibodies to recombinant mitochondrial proteins in patients with primary biliary cirrhosis. N Engl J Med 320:1377-80, 1989.
26. Leung PSC, Iwayama T, Prindiville T, et al: Use of designer recombinant mitochondrial antigens in the diagnosis of primary biliary cirrhosis. Hepatology 15:367-72, 1992.
27. Moteki S, Leung PSC, Coppel RL, et al: Use of designer triple expression hybrid clone for three different lipoyl domains for the detection of anti-mitochondrial antibodies. Hepatology 24 97-103, 1996.
28. Moteki S, Leung PSC, Dickson ER, et al: Epitope mapping and reactivity of autoantibodies to the E2 component of 2-oxoglutarate dehydrogenase complex (OGDC-E2) in primary biliary cirrhosis using recombinant OGDC-E2. Hepatology 23:436-44, 1996.
29. Toh BH: Smooth muscle autoantibodies and autoantigens. Clin Exp Immunol 38:621-8, 1979.
30. Rizzeto M, Swana G, Doniach D: Microsomal antibodies in active chronic hepatitis and other disorders. Clin Exp Immunol 15-331-44, 1973.
31. Manns MP, Griffin KJ, Sullivan KF, Johnson EF: LKM-1 autoantibodies recognize a short linear sequence in P450 IID6, a cytochrome P-450 monooxygenase. J Clin Invest 188:1370-8, 1991.
32. Gershwin ME: The molecular basis of primary biliary cirrhosis. interfacing clinical medicine and wet bench research. Isr J Med Sci 31:22-30, 1995.
33. Leung PSC, Manns MP, Gershwin ME: Inflammatory hepato-biliary cirrhosis. In: Rich RR (ed): Clinical immunology. principles and practice Vol. II. St. Louis, Mosby-Year Book, 1996, pp 1429-43.
34. Iwayama T, Leung PSC, Rowley M, et al: Comparative immunoreactive profiles of Japanese and American patients with primary biliary cirrhosis against mitochondrial autoantigens. Intl Arch All Immunol 99.28-33, 1992.
35. Leung PSC, Van de Water J, Coppel RL, Gershwin ME: Molecular characterization of the mitochondrial autoantigens in primary biliary cirrhosis. Immunol Res 10:518-27, 1991.
36. Surh CD. Coppel R, Gershwin ME: Structural requirement for autoreactivity on human pyruvate dehydrogenase-E2, the major autoantigen of primary biliary cirrhosis. Implication for a conformational autoepitope. J Immunol 144:3367-74, 1990.
37. Leung PSC, Iwayama T, Coppel RL, Gershwin ME: Site-directed mutagenesis of lysine within the immunodommant autoepitope of PDC-E2. Hepatology 12:1321-8, 1990.
38. Fussey SP, Ali ST, Guest JR, et al: Reactivity of primary biliary cirrhosis sera with Escherichia coli dihydrolipoamide acetyltransferase (E2p): characterization of the main immunogenic region. Proc Natl Acad Sci USA 87.3987-91, 1990.
39. Tuaillon N, Andre C, Briand JP, et al: A lipoyl synthetic octadecapeptide of dihydrolipoamide acetyltransferase specifically recognized by anti-M2 autoantibodies in primary biliary cirrhosis. J Immunol 148:445-50, 1992.
40. Quinn J, Diamond AG, Palmer JM, et al: Lipoylated and unlipoylated domains of human PDC-E2 as autoantigens in primary biliary cirrhosis: significance of lipoate attachment. Hepatology 18:1384-91, 1993.
41. Iwayama T, Leung PSC, Coppel RL, et al: Specific reactivity of recombinant human PDC-E1 alpha in primary biliary cirrhosis. J Autoimm 4 769-78, 1991.
42. Fregeau DR, Roche TE, Davis PA, et al: Primary biliary cirrhosis. Inhibition of pyruvate dehydrogenase complex activity by autoantibodies specific for E1 alpha, a non-lipoic acid containing mitochondrial enzyme. J Immunol 144:1671-6, 1990.
43. Surh CD, Cooper AE, Coppel RL, et al: The predominance of IgG3 and IgM isotype antimitochondrial autoantibodies against recombinant fused mitochondrial polypeptide in patients with primary biliary cirrhosis. Hepatology 8:290-5, 1988.
44. Kaplan MM: Primary biliary cirrhosis. Review. N Engl J Med 316:521-8, 1987.
45. James SP: Primary biliary cirrhosis and primary sclerosing cholangitis. In: Targan SR, Shanahan F (eds) Immunology and immunopathology of the liver. New York: Igaku Shoin, 1990, pp 235-54.
46. Van de Water J, Turchany J, Leung PSC, et al: Molecular mimicry in primary biliary cirrhosis. Evidence for biliary epithelial expression of a molecule cross-reactive with pyruvate dehydrogenase complex - E2. J Clin Invest 91:2653-64, 1993.
47. Nakanuma Y, Tsuneyama K, Gershwin ME, Yasoshima M: Pathology and immunopathology of primary biliary cirrhosis with emphasis on bile duct lesions: recent progress. Sem Liv Dis 15:313-28, 1995.
48. Tsuneyama K, Van de Water J, Nakanuma Y, et al: Human combinatorial autoantibodies and mouse monoclonal antibodies to PDC-E2 produce abnormal apical staining of salivary glands in patients with coexistent primary biliary cirrhosis and Sjogren's syndrome. Hepatology 20.893-8, 1994.
49. Nakanuma Y, Tsuneyama K, Kono N, et al: Biliary epithelial expression of pyruvate dehydrogenase complex in primary biliary cirrhosis: an immunohistochemical and immunoelectron microscopic study. Hum Pathol 26:92-8, 1995.
50. Cha S, Leung PSC, Coppel RL, et al: Heterogeneity of combinatorial human autoantibodies against PDC-E2 and biliary epithelial cells in patients with primary biliary cirrhosis. Hepatology 20:574-83, 1994.
51. Cha S, Leung PSC, Gershwin ME, et al: Combinatorial autoantibodies to dihydrolipoamide acetyltransferase, the major autoantigen of primary biliary cirrhosis. Proc Natl Acad Sci USA 90:2527-31, 1993.
52. Joplin R, Lindsay JG, Hubscher SG, et al: Distribution of dihydrolipoamide acetyltransferase (E2) in the liver and portal lymph nodes of patients with primary biliary cirrhosis: an immunohistochemical study. Hepatology 14:442-7, 1991.
53. Joplin R, Lindsay JG, Johnson GD, et al: Membrane dihydrolipoamide acetyltransferase (E2) on human biliary epithelial cells in primary biliary cirrhosis. Lancet 339:93-4, 1992.
54. Joplin RE, Johnson GD, Matthews JB, et al: Distribution of pyruvate dehydrogenase dihydrolipoamide acetyltransferase (PDC-E2) and another mitochondrial marker in salivary gland and biliary epithelium from patients with primary biliary cirrhosis. Hepatology 19:1375-80, 1994.
55. Joplin R, Wallace LL, Johnson GD, et al: Subcellular localization of pyruvate dehydrogenase dihydrolipoamide acetyltransferase in human intrahepatic biliary epithelial cells. J Pathol 176:381-90, 1995.
56. Leung PSC, Krams S, Munoz S, et al: Characterization and epitope mapping of human monoclonal antibodies to PDC-E2, the immunodominant autoantigen of primary biliary cirrhosis. J Autoimmunol 5:703-18, 1992
57. Pollack M, Raubitschek AA, Larrick JW: Human monoclonal antibodies that recognize conserved epitopes in the core-lipid A region of liposaccharides. J Clin Invest 79:1421-38, 1987.
58. Huse WD, Sastry L, Iverson SA, et al: Generation of a large combinatorial library of the immunoglobulin repertoire in phage lambda. Science 246:1275-81, 1989.
59. Pascual V, Cha S, Gershwin ME, et al: Nucleotide sequence analysis of natural and combinatorial anti-PDC-E2 antibodies in patients with primary biliary cirrhosis. Recapitulating immune selection with molecular biology. J Immunol 152: 2577-85, 1994.
60. Pascual V, Verkruyse L, Casey ML, Capra JD: Analysis of immunoglobulin heavy chain gene segment utilization in human fetal liver: revisiting the proximal utilization hypothesis. J Immunol 151:4164-72, 1993.
61. Berman JE, Melis SJ, Pollock R, et al. Content and organization of the human Ig VH locus: definition of three new families and linkage to the Ig CH locus. EMBO 7:727-38, 1988.
62. Cairns E, Kwong PC, Misener V, et al: Analysis of variable region genes encoding a human anti-DNA antibody of normal origin. J Immunol 143:685-91, 1989.
63. Pascual V, Victor K, Randen I, et al: Nucleotide sequence analysis of rheumatoid factors and polyreactive antibodies derived from patients with rheumatoid arthritis reveals diverse use of VH and VL gene segments and extensive variability in CDR3. Scand J Immunol 36:349-62, 1992.
64. Tomlinson IM, Walter G, Marks JD, et al: The repertoire of human germline VH sequences reveals about fifty groups of VH segments with different hypervariable loops. J Mol Biol 227:776-98, 1992.
65. Humphries CG, Shen A, Kuziel WA, et al: A new human immunoglobulin Vh family preferentially rearranged in premature B-cell tumors. Letter. Nature 331:446, 1988.
66. Mathyssens G, Rabbits H: Structure and multiplicity of genes for the human immunoglobulin heavy chain variable region. Proc Natl Acad Sci USA 77:6561-70, 1980.
67. Lee KH, Matsuda F, Kinashi T, et al: A novel family of variable genes of the human immunoglobulin heavy chain. J Mol Biol 195:761-8, 1987
68. Chuchana P, Blancher A, Brockly F, et al: Definition of the human immunoglobulin variable lambda (IGLV) gene subgroups. Eur J Immunol 20:1317-25, 1990.
69. Fukishima N, Nakamura M, Matsui M, et al: Establishment and structural analysis of human mAb to the E2 component of the 2-oxoglutarate dehydrogenase complex generated from a patient with primary biliary cirrhosis. Int Immunol 7:1047-55, 1995.
70. Dersimonian H, Schwartz RS, Barret KJ, Stollar BD: Relationship of human variable region heavy chain germline genes to genes encoding anti-DNAS antibodies. J Immunol 129:2496-2501, 1987.
71. Sanz I, Dang H, Taeki M, et al: VH sequence of a human antiSm antibody. Evidence that autoantibodies can be unmutated copies of germline genes. J Immunol 142:883-7, 1989.
72. Robbins DL, Kenny TP, Coloma MJ, et al: Serological and molecular characterization of a human monoclonal rheumatoid factor derived from rheumatoid synovial cells. J Rheum 33:1188-95, 1990.